Translational Oncology · 2018 · 23 citations · 38 references
MedicineCancer BiologyOncologyBreast OncologyMolecular OncologyTumor ProgressionBreast Cancer OncologyCancer BiomarkersCancer Stem CellsCancer Survival AnalysisEndocrine Tumor PrognosisAndrogen Receptor ExpressionBreast Cancer PrognosisCancer Stem Cell MarkersCd44 ExpressionDisease-free Survival AnalysisImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical Markers
BACKGROUND: Androgen receptor (AR) has emerged as a significant prognostic marker in early breast cancer (BCa). Association of AR with cancer stem cell (CSC) markers in BCa is unknown. Aim of the present study was to evaluate the immunohistochemical expression of AR, CD44, CD24 and ALDH1 in a cohort of Pakistani patients diagnosed with invasive BCa and to correlate the expression with 5- year disease free survival. PATIENTS AND METHODS: We evaluated immunohistochemical expression AR, CD44, CD24 and ALDH1 in formalin fixed paraffin embedded archival blocks of 166 cases of primary invasive BCa (stage I-III) and correlated the expression with clinicopathological variables and outcome using univariable and multivariable analysis. Survival data was computed by Kaplan Meier curves. RESULTS: ) did not correlate with adverse outcome (P > .05). However, AR expression retained the association with better prognosis even in patients whose tumors exhibited a CSC phenotype. CONCLUSIONS: Expression of AR and CD24 in stage I-III invasive BCa correlates with favorable clinicopathological features and delineates a subgroup of patients with better disease-free survival.
38
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text
Medicine, Cell Biology, Oncology +11
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations
Medicine, Cancer Biology, Oncology +16
Prognostic markers in triple‐negative breast cancer
Emad A. Rakha, Maysa E. El‐Sayed, Andrew R. Green et al. · Cancer · 2006 · 1.3K citations
Medicine, Oncology, Breast Oncology +16